Feasibility Study SA of the Supira System for HRPCI

计划入组 71 人 · 首次发布于 2023 年 5 月 18 日

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

计划入组 15 人 · 首次发布于 2023 年 10 月 18 日

A Safety and Effectiveness Study of the Supira System in Patients Undergoing HRPCI - CE Study

计划入组 135 人 · 首次发布于 2024 年 8 月 21 日

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Medical Cannabis

Medical air

Aethlon Medical

Vivani Medical

United States

Journey Medical

United States

Supira Medical Raises $120M in Series E Funding, Completes SUPPORT I Enrollment for Novel Cardiac Support Device

Supira Medical Initiates U.S. Feasibility Study for High-Risk PCI with Novel pVAD

Supira Medical Receives FDA Approval for SUPPORT II Pivotal Trial of Next-Generation Percutaneous Ventricular Assist Device